Second-Line Treatment Approaches for R/R DLBCL
An expert provides his perspective on the first- and second-line treatment approaches in the patient case and comments on the patient’s likely prognosis.
EP: 1.Introduction: A 68-Year-Old Man with Diffuse Large B-Cell Lymphoma
EP: 2.Second-Line Treatment Approaches for R/R DLBCL
EP: 3.Available Treatment Options in DLBCL with 2 or More Relapses
EP: 4.An Oncologist’s Perspective on Future Treatment Options for the Profiled Patient and Targeted Treatment Approaches in R/R DLBCL
EP: 5.Critical Unmet Needs in DLBCL
Different Options Discussed for DLBCL in Later-Lines of Treatment
June 13th 2024During a Case-Based Roundtable® event, Matthew Ulrickson, MD, considered treatments for patients with relapsed/refractory diffuse large B-cell lymphoma with event participants in the second article of a 2-part series.
Read More
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen
CAR T-Cell Therapy Presents a Paradigm Changing Option in DLBCL
May 23rd 2024During a Case-Based Roundtable® event, Sairah Ahmed, MD, discussed how the burgeoning use of chimeric antigen receptor T-cell therapy presents a paradigm shift in treatment for patients with diffuse large B-cell lymphoma in the first article of a 2-part series.
Read More
